Meridian Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Buy
576
+16
+3% +$16.2K 0.07% 65
2025
Q4
$601K Sell
560
-16
-3% -$15.3K 0.08% 53
2025
Q3
$439K Sell
576
-92
-14% -$68.5K 0.06% 68
2025
Q2
$520K Buy
668
+43
+7% +$33.4K 0.08% 59
2025
Q1
$516K Sell
625
-47
-7% -$39.1K 0.08% 57
2024
Q4
$519K Buy
672
+6
+0.9% +$4.97K 0.08% 59
2024
Q3
$590K Sell
666
-11
-2% -$9.89K 0.09% 54
2024
Q2
$613K Sell
677
-45
-6% -$36K 0.11% 50
2024
Q1
$562K Buy
722
+115
+19% +$81.8K 0.1% 49
2023
Q4
$354K Buy
607
+32
+6% +$18.7K 0.07% 65
2023
Q3
$309K Buy
575
+22
+4% +$11.3K 0.06% 70
2023
Q2
$259K Buy
+553
New +$232K 0.05% 79
2021
Q2
Sell
-289
Closed -$54K 740
2021
Q1
$54K Buy
289
+93
+47% +$18.2K 0.02% 150
2020
Q4
$33K Sell
196
-7
-3% -$1.04K 0.01% 166
2020
Q3
$30K Hold
203
0.02% 166
2020
Q2
$33K Sell
203
-1
-0.5% -$153 0.02% 158
2020
Q1
$28K Buy
204
+18
+10% +$2.47K 0.02% 154
2019
Q4
$24K Buy
+186
New +$21.6K 0.02% 188

Other funds holding LLY

Meridian Wealth Partners's LLY Position: Q1 2026 in Review

Meridian Wealth Partners increased its Eli Lilly (LLY) stake by 2.9% in Q1 2026, buying an estimated $16.2K and bringing the position to 576 shares worth $529K. The position accounts for 0.07% of the portfolio, ranked #65.

Meridian Wealth Partners first reported a position in LLY in Q4 2019 and has held it in 18 quarters since. The position peaked at $613K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Meridian Wealth Partners held 576 shares of Eli Lilly worth $529K as of Q1 2026.
  • Meridian Wealth Partners bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.07% of Meridian Wealth Partners's portfolio in Q1 2026, its #65 holding.
  • Meridian Wealth Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 18 quarters since.
  • Meridian Wealth Partners's Eli Lilly position peaked at $613K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meridian Wealth Partners's 13F filing for Q1 2026, filed 14 May 2026.